Tricell Bio

Tricell Bio is a South Korean biotechnology company specializing in regenerative medicine and advanced cell therapy solutions. The company is recognized for its proprietary TriCell platform, which includes specialized medical devices for the efficient concentration of Platelet-Rich Plasma (PRP) and Bone Marrow Concentrate (BMC). Beyond its commercialized device portfolio, Tricell Bio is advancing a therapeutic pipeline of mesenchymal stem cell (MSC) therapies targeting degenerative and inflammatory conditions. Their lead program, TC-101, is being developed for the treatment of osteoarthritis, while earlier-stage programs explore indications such as atopic dermatitis and graft-versus-host disease. Headquartered in the Pangyo Techno Valley, the company integrates medical device innovation with biological drug development to provide comprehensive regenerative treatments.